Reviewed & approved by Dr. Nova Reyes · Last checked 2026-10-25. ← Back to Evidence Library

Thymulin: what the evidence says

At a glance

Thymulin has no published treatment trials in people that we found. Unknown

What it is: a 9-amino-acid hormone made by the thymus. It needs zinc to be active, and blood levels fall with age. R1, R2

What the evidence says: mouse studies only for giving thymulin. Human studies measure the body's own thymulin, for example rising with zinc-fortified milk in very old people. R1, R2

Biggest risks: unknown in humans. Unknown

Rating

Human Human evidence No human data: no study gave thymulin to people. The one human study we cite measured the body's own thymulin after zinc-fortified milk R1
Animal Animal evidence Mouse studies R2
Regulatory Not FDA-approved (no Drugs@FDA record) · Not approved as a medicine anywhere in the world · WADA 2026: S0 (unapproved substances) applies R3
Established human dose None. Never tested in people

Evidence verdict: Human: No human data · Animal: mouse studies Card verdict: No human data (immune claims rest on mouse injection studies and human endogenous blood-level studies)

This page reports what studies used. It is not dosing advice.

Legend: HUMAN data · ANIMAL / LAB data · UNKNOWN · UNVERIFIED: not yet confirmed against a primary source

What is it?

Thymulin (once called "facteur thymique sérique") is a zinc-dependent thymic hormone involved in T-cell maturation. R1

Does it work?

Is it safe?

Gray-market "research use only" Thymulin: extra risks

Unknown contents. Products sold online as "research use only" or "not for human use" are not made under drug-quality rules, so identity, strength and sterility are unknown. This is a general caution; we have not found testing data for this product specifically. Unknown

What we don't know

Is it legal?

Not FDA-approved (no Drugs@FDA record, openFDA query Oct 24, 2026) and not approved as a medicine anywhere in the world. WADA: not named on the 2026 Prohibited List; S0 bans at all times any unapproved substance in development that no other section covers, which describes Thymulin R3. WADA has not ruled on Thymulin by name.

Study details

These are doses researchers used, not recommendations.

R1 Human Human: Zinc-fortified milk pilot (Costarelli 2014)

Study People / model Route Dose used Follow-up Reported Side effects / dropouts Citation
Costarelli 2014 Very old adults, crossover Oral (zinc milk) Zinc amounts not in abstract 2 months Higher thymulin activity Not in abstract PMID 24771015

R2 Animal Animal (Kanemaru 2026)

Study People / model Route Dose used Follow-up Reported Side effects / dropouts Citation
Kanemaru 2026 Aged mice Injection See paper — Less myeloid inflammation; better tumour control with anti-PD-L1 Not in abstract PMID 42481458

Full reference list (PubMed entries verified Oct 24, 2026)

  1. R1 Costarelli L, et al. Age (Dordr). 2014;36(3):9656. PMID 24771015
  2. R2 Kanemaru H, et al. Nat Commun. 2026;17(1):6534. PMID 42481458
  3. R3 WADA. World Anti-Doping Code International Standard: Prohibited List 2026 (in force Jan 1, 2026). https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf (text read Oct 24, 2026)

Disclaimer

This page summarizes published research for education and harm reduction; it is not medical advice or a recommendation to use Thymulin. Talk to a clinician you trust before using any drug, and report side effects to FDA MedWatch.

Approved for Adam Greene by Dr. Nova Reyes, 2026-10-25.